Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988;13(2):145-51.
doi: 10.1007/BF01889044.

Progressive CT appearance of hepatic metastases from colorectal carcinoma

Affiliations

Progressive CT appearance of hepatic metastases from colorectal carcinoma

J G Letourneau et al. Gastrointest Radiol. 1988.

Abstract

An 8-year retrospective review of 106 serial computed tomographic (CT) examinations performed on 32 patients with colorectal carcinoma metastatic to the liver was done to determine if the CT appearance of such metastases changed with a favorable response to chemotherapy or with progression of disease. Of these 32 patients, 15 underwent placement of an infusion pump for delivery of chemotherapy directly into the hepatic artery, 3 underwent partial hepatectomy, 1 underwent both procedures, and 13 underwent neither. Regression of hepatic metastases (7 patients), only seen following infusion pump placement, was associated with a decrease in size and an increase in margination of lesions. In two of these patients regression of metastases was seen in one area of the liver with subsequent progression or development of metastases in another region, presumably due to preferential delivery of chemotherapeutic agent. Progression of disease (23 patients) was associated with an increase in both size and number of lesions that became progressively less well marginated. Development of poorly marginated or infiltrative characteristics at the periphery of the lesion was associated with a poor prognosis. Thus, the CT characteristics of hepatic metastases from colorectal carcinoma differ with a favorable response to chemotherapy and with progression of disease.

PubMed Disclaimer

Similar articles

References

    1. Gastrointest Radiol. 1981 Jan 15;6(1):79-84 - PubMed
    1. Radiology. 1984 Mar;150(3):661-5 - PubMed
    1. Cancer Treat Rep. 1978 May;62(5):699-703 - PubMed
    1. AJR Am J Roentgenol. 1985 Mar;144(3):577-9 - PubMed
    1. Gastroenterology. 1983 Sep;85(3):596-9 - PubMed